Ingentium Magazine

The next generation in scientific exploration and research

Skip to content
  • Disease Networks
    • Melanoma
    • Parkinson’s Disease
    • Huntington’s Disease
    • Major Depressive Disorder
    • Autism
    • Coronavirus
    • Tuberculosis
    • Chikungunya
  • Resources
  • About Ingentium

Melanoma Media

Drs Dalvin & Dr Basil Williams: Unpacking uveal melanoma care – Dr Lauren Dalvin & Dr Basil Williams
August 2, 2025August 2, 2025

Drs Dalvin & Dr Basil Williams: Unpacking uveal melanoma care – Dr Lauren Dalvin & Dr Basil Williams

Melanoma Media
Read more
Ask The Expert: 2025 ASCO Highlights for the Ocular Melanoma Community
July 29, 2025July 29, 2025

Ask The Expert: 2025 ASCO Highlights for the Ocular Melanoma Community

Melanoma Media
Read more
RELATIVITY-098: nivolumab and relatlimab in stage III-IV melanoma
July 26, 2025July 26, 2025

RELATIVITY-098: nivolumab and relatlimab in stage III-IV melanoma

Melanoma Media
Read more
Adding sarilumab to checkpoint inhibitors improves melanoma response and reduces toxicity
July 23, 2025

Adding sarilumab to checkpoint inhibitors improves melanoma response and reduces toxicity

Melanoma Media
Read more
C-IT Neo trial interim results support immune based imaging tools
July 19, 2025July 19, 2025

C-IT Neo trial interim results support immune based imaging tools

Melanoma Media
Read more
How will future trials refine insights provided by DREAMseq in melanoma?
July 19, 2025

How will future trials refine insights provided by DREAMseq in melanoma?

Melanoma Media
Read more
Final DREAMseq results favor first-line immunotherapy for melanoma
July 19, 2025July 19, 2025

Final DREAMseq results favor first-line immunotherapy for melanoma

Melanoma Media
Read more
Ask The Expert: Focusing on the Liver: Treatment Approaches in Metastatic Ocular Melanoma
July 19, 2025

Ask The Expert: Focusing on the Liver: Treatment Approaches in Metastatic Ocular Melanoma

Melanoma Media
Read more
Targeting DNA methylation enhances immunotherapy response in PD-1 resistant melanoma
July 19, 2025July 19, 2025

Targeting DNA methylation enhances immunotherapy response in PD-1 resistant melanoma

Melanoma Media
Read more
2025 UNC Patient & Caregiver Symposia: Three Decades as a Melanoma Surgeon
July 17, 2025July 17, 2025

2025 UNC Patient & Caregiver Symposia: Three Decades as a Melanoma Surgeon

Melanoma Media
Read more

Posts navigation

Older posts

Recent Articles

  • Cutaneous Epithelioid/Pleomorphic Rhabdomyosarcoma, Melanoma in Disguise? An Immunohistochemical, Molecular and Epigenetic Study of 13 Patients.

    March 6, 2026

  • Intracellular cyclization-coupled peptide library screening yields potent transcription factor antagonists.

    March 6, 2026

  • Melanoma risk awareness and sun-protective behavior: Does the sun only hurt on the beach? A cross-sectional survey on 1288 families of a Mediterranean population.

    March 6, 2026

Trending Articles

  • [Aggregator] Downloaded image for imported item #588150Seroprevalence of coronaviruses of cattle and pigs… November 14, 2025
  • [Aggregator] Downloaded image for imported item #588150Adenoviral Inciting Antigen and Somatic… February 13, 2026
  • [Aggregator] Downloaded image for imported item #588150Therapeutic Approaches to Treat SARS-CoV-2. February 28, 2026
ingentium

Ingentium Inc.
Email: support@ingentium.com

Wildcard SSL

Additional

  • Contact Us
  • Terms of Service Agreement

Disease Networks

  • Melanoma
  • Parkinson’s Disease
  • Huntington’s Disease
  • Major Depressive Disorder
  • Autism
  • Coronavirus
  • Tuberculosis
  • Chikungunya
Copyright © 2016-2026 All rights reserved.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}